Revenue
$37.24B
Gross Margin
+71.5%
Operating Margin
+31.6%
Net Margin
+20.9%
Income statement waterfall for Amgen (AMGN) — TTM through Q1 2026
Net income: $7.80B
Margin breakdown for Amgen (AMGN) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $37.24B | $37.24B |
| Cost of Revenue | −$10.63B | $26.61B |
| Gross Profit | $26.61B | $26.61B |
| Operating Expenses | −$14.83B | $11.78B |
| Operating Income | $11.78B | $11.78B |
| Other Income / Expense | −$2.69B | $9.09B |
| Pre-tax Income | $9.09B | $9.09B |
| Income Tax | −$1.29B | $7.80B |
| Net Income | $7.80B | $7.80B |
- Revenue$37.24B
- Cost of Revenue−$10.63B
- Gross Profit$26.61B
- Operating Expenses−$14.83B
- Operating Income$11.78B
- Other Income / Expense−$2.69B
- Pre-tax Income$9.09B
- Income Tax−$1.29B
- Net Income$7.80B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement